The Bank of New York Mellon Corporation (NYSE: BK) topped analysts’ forecasts on earnings for the second quarter of 2019 while revenues matched expectations. The stock was up 0.90% in premarket hours on Wednesday.
Total revenue decreased 5% to $3.9 billion from last year, reflecting lower fee and net interest revenues, but the results were in line with estimates.
Net income fell 8% year-over-year to $969 million while EPS dropped 2% to $1.01. Analysts had forecast EPS of $0.95.
Fee revenue decreased 3%, mainly due to cumulative AUM outflows, negative impacts from a strong US dollar and lower foreign exchange and securities lending revenue. Net interest revenue declined 12%, hurt by higher deposit and funding costs and the impact of hedging activities.
In the Investment Services business, total revenues fell 3%. Within this business, the company saw revenue growth on a year-over-year basis in most of its divisions except for Asset Servicing and Treasury Services. The decreases in these two divisions were mainly due to lower net interest revenue.
In the Investment Management business, total revenues decreased 10%. Within the segment, revenues declined in both the Asset Management and Wealth Management divisions year-over-year due to various factors including impacts from divestitures and hedging activities and lower net interest revenue.
Assets under custody and/or administration (AUC/A) and assets under management (AUM) both saw single-digit increases, helped by higher market values and net new business.
In a separate release, the company declared a quarterly common stock dividend of $0.31 per share, payable on August 9, 2019 to shareholders of record on July 29, 2019.
https://www.youtube.com/watch?v=50yUaLybUnA&t=667s China-based internet search firm Baidu Inc. (NASDAQ: BIDU) reported financial results for the second quarter of 2020 on Thursday after the market's close. Earnings exceeded analysts’ expectations, but the
Applied Materials' (NASDAQ: AMAT) earnings and revenue for the third quarter exceeded the market's views. Adjusted EPS of $1.06 and revenue of $4.40 billion in Q3, grew 43% and 23%,
A lot of stocks in the biotech space have skyrocketed this year after their announcements and advances in finding a vaccine or in the treatment of COVID-19. While these companies